Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects
Chemistry & Biodiversity · 2026-06 · 23 (6)
DOI: 10.1002/cbdv.71416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 18.06.2026. Verfasst von Serhii Sinyavskyi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry and Geology, Oles Honchar Dnipro National University, Dnipro, Ukraine. Hauptthemen laut MEDLINE: Triazines, Antineoplastic Agents, Drug Design, Triazoles. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Ministry of Education and Science of Ukraine, Ministry of Foreign Affairs of the Czech Republic.
Abstract (Originalsprache)
A strategy has been developed for identification of biologically active compounds among unknown benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines, based on the application of conformational restriction in the series of ([2‐(3‐R‐1 H ‐[1,2,4]triazol‐5‐yl)phenyl]amines with known chemotherapeutic activity. The target compounds were synthesized by diazotization of the corresponding ([2‐(3‐R‐1 H ‐[1,2,4]triazol‐5‐yl)phenyl]amines followed by cyclization of the formed diazo‐compounds. The structures of products have been proven by IR, LC–MS, NMR spectroscopy, and x‐ray structural analysis. Cytotoxicity screening was performed on a panel of cell lines derived from various tumor types and pseudo‐normal cell lines. It was demonstrated that benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines have selective antiproliferative activity against Jurkat cell lines with IC 50 ranging from 7.64 to >100 µM. We identified 2‐(naphthaline‐1‐ylmethyl)benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazine ( 2e ) with high cytotoxic activity against this cell line with an IC 50 of 7.64 µM. It is noteworthy that the conformational restrictions imposed proved to be a promising strategy for searching for biologically active compounds, and additional structural modification may lead to more effective and promising antitumor agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry and Geology, Oles Honchar Dnipro National University, Dnipro, Ukraine.
- National University «Zaporizhzhia Polytechnic», Zaporizhzhia, Ukraine.
- Zaporizhzhia State Medical and Pharmaceutical University, Zaporizhzhia, Ukraine.
- Institute of Organic Chemistry of the National Academy of Sciences of Ukraine, Kyiv, Ukraine.
- Institute of Cell Biology of the National Academy of Sciences of Ukraine, Lviv, Ukraine.
- Molecular Design Center, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
ORCID-Profile: Oleksii Antypenko
Förderung
- Ministry of Education and Science of Ukraine
- Ministry of Foreign Affairs of the Czech Republic
Zitieren
APA
Sinyavskyi, S., Koptieva, S., Voskoboinik, O., Antypenko, O., Bohdan, N., Kozak, Y., Shishkina, S., & Kovalenko, S. (2026). Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects. Chemistry & Biodiversity, 23(6). https://doi.org/10.1002/cbdv.71416
Vancouver
Sinyavskyi S, Koptieva S, Voskoboinik O, Antypenko O, Bohdan N, Kozak Y, et al. Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects. Chemistry & Biodiversity. 2026;23(6). doi:10.1002/cbdv.71416
BibTeX
@article{Sinyavskyi2026,
author = {Sinyavskyi, Serhii and Koptieva, Svitlana and Voskoboinik, Oleksii and Antypenko, Oleksii and Bohdan, Natalia and Kozak, Yuliia and Shishkina, Svetlana and Kovalenko, Serhii},
title = {Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {6},
doi = {10.1002/cbdv.71416}
}
EUVIMED